Real-time enrollment status for this advanced non-small cell lung cancer with kras g12c mutation clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:26 AM UTC
| NCT Number | NCT05815173 |
| Recruiting Status | Recruiting |
| Condition | Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 6 sites in the US |
| Sponsor | NYU Langone Health |
| Last Updated on CT.gov | December 30, 2025 (Dec 30, 2025) |
As of August 28, 2026: Clinical trial NCT05815173 is currently recruiting participants. This phase1 study for advanced non-small cell lung cancer with kras g12c mutation is actively seeking new participants at 6 locations across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05815173 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05815173 was last updated Dec 30, 2025 (December 30, 2025). HelloStudys verifies this status automatically.